超越安全性:基于细胞的癌症疗法中的自杀系统
1Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Trends in cancer
|July 4, 2025
概括
诱导性自杀基因系统通过触发受控细胞死亡来增强固体瘤的细胞疗法. 这种策略克服了瘤抵抗和免疫抑制,安全地提高了抗瘤免疫力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 固体瘤对基于细胞的治疗提出了挑战,包括异质性,抗原逃逸和免疫抑制微环境.
- 诱导性自杀基因系统主要是治疗细胞的安全特征.
- 通过这些系统可以实现对治疗细胞的控制消除.
研究的目的:
- 探索诱导性自杀基因系统在增强基于细胞的癌症疗法的低估潜力.
- 要突出控制细胞死亡如何克服固体瘤治疗的局限性.
- 强调这些系统在提高效率和确保安全方面的双重作用.
主要方法:
- 关于用于细胞治疗的诱导性自杀基因系统的最新进展的审查.
- 对触发受控细胞死亡的机制 (前药物,配体,抗体,小分子) 的分析.
- 研究免疫细胞死亡 (ICD) 诱导及其对瘤微环境 (TME) 的影响.
主要成果:
- 控制细胞死亡,特别是通过ICD,可以消除耐药瘤细胞.
- 诱导性自杀系统可以将免疫抑制性TME重新编程为刺激性TME.
- 这些系统提供了一种扩大抗瘤反应的方法.
结论:
- 将诱导性自杀基因系统集成到细胞疗法中,具有变革性的潜力.
- 这些系统可以克服固体瘤治疗中的关键有效性障碍.
- 对细胞的控制消除提高了安全性,同时放大了治疗结果.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


